Home - Kumar Group

Welcome to Our Group

We are delighted to have you explore our research. Our group is dedicated to advancing the frontiers of organic chemistry, medicinal chemistry, and drug discovery.

Our research centres on the discovery and development of novel bioactive molecules for industrial and medical applications. Naturally produced chemicals play fundamental roles in biological systems, yet many are available only in trace amounts. Through innovative organic synthesis, we access these molecules and their analogues, enabling full assessment of biological activity, mode of action, and the development of new therapeutic leads. Our work is multi-disciplinary, combining synthetic organic chemistry, molecular modelling, and biological screening.

Our Research

Discover our research areas in Organic chemistry and drug discovery

Explore All Research

Organic/Medicinal Chemistry

Our group focuses on the design and synthesis of novel drug candidates for various therapeutic targets, with a particular emphasis on cancer and infectious diseases.

Drug Discovery

We employ state-of-the-art techniques in Organic/Medicinal Chemistry, including structure-based drug design, fragment-based drug discovery, and high-throughput screening.

Chemical Biology

Our research integrates chemical synthesis with biological studies to understand disease mechanisms and develop new therapeutic strategies.

Computational Drug Discovery

We use AI, machine learning, deep learning, molecular docking, and simulation to accelerate drug discovery and design.

Latest News

Congratulations to Rasel Khan on New Bioorganic Chemistry Publication

September 30, 2026

What if, instead of killing bacteria, we could simply put them to sleep? Congratulations to Rasel Ahmed Khan and co-authors on a new Bioorganic Chemistry paper describing novel quinazolinone-based PqsR...

Congratulations to Rasel Khan on New Bioorganic Chemistry Publication

September 30, 2026

What if, instead of killing bacteria, we could simply put them to sleep? Congratulations to Rasel Ahmed Khan and co-authors on a new Bioorganic Chemistry paper describing novel quinazolinone-based PqsR...

Congratulations to Ghayah Bahatheg on New RSC Advances Publication

September 22, 2026

What if we could keep everything that makes antimicrobial peptides powerful, and lose what holds them back? Congratulations to Ghayah Bahatheg and co-authors on a new RSC Advances review of...

Kumar Group at Southern Highlands Conference on Heterocyclic Chemistry 2026

September 05, 2026

Josh Fleming and Tope A. Ibisanmi represented the Kumar Research Group at the Southern Highlands Conference on Heterocyclic Chemistry 2026 at The Sebel Harbourside Kiama, presenting posters and joining close-knit...

Congratulations to Dittu and Robert on Their PhD Graduation

August 26, 2026

The Kumar Research Group congratulates Dr Dittu Suresh and Dr Robert Rourke on their PhD graduation. We celebrate their dedication, thank Professor Naresh Kumar for his support, and share moments...

Congratulations to Sam Attard on New RSC Advances Publication

August 07, 2026

Congratulations to Samuel T. Attard and co-authors on a new RSC Advances paper reporting nitric oxide–releasing conjugated ortho-hindered nitroarenes (CONAs) as dual-action antimicrobial peptide-mimics.

Congratulations to Josh Fleming on His PhD Scholarship

July 31, 2026

Congratulations to Josh Fleming on receiving a PhD scholarship. The Kumar Research Group celebrates his dedication through Honours and looks forward to the next chapter of his research journey.

View All News